Unethical pharmaceutical marketing: a common problem requiring collective responsibility | The
BMJ Skip to main content Intended for healthcare professionals Access provided by Google …

The relationships between innovation and firm misconduct have received little attention. We
contribute to advancing understanding of misconduct in several ways. First, we find support …

Medical pharmaceutical and device manufacturers are essential in making products that
benefit patients, and collaboration between health care clinicians and the industry is …

The pharmaceutical industry plays a central role in the production of the drugs we use to
treat most illnesses. It is immensely powerful and has received sustained attention from …

Abstract Context: The False Claims Act is the US federal government's primary tool for
identifying and penalizing pharmaceutical fraud. The Department of Justice uses the False …

Interfirm self‐regulation through trade associations is common but its effectiveness is
debated and likely varies by time, country, and industry. This study examines self‐regulation …

Nos propusimos discernir en qué medida las estrategias mediáticas adoptadas en torno a
las vacunas contra la COVID-19, a lo largo de los primeros 15 meses desde el comienzo de …

T he ongoing opioid epidemic has led to hundreds of lawsuits against opioid manufacturers
alleging illegal marketing practices, which have upended the industry. While the early …

Introduction With the rapid development of China's pharmaceutical industry, issues of
corruption and regulatory effectiveness have become increasingly prominent, posing critical …

The Australian Government has implemented a myriad of restraint tools, bulletins, policies,
reform documents and legislation restricting the use of physical and chemical restraint use in …